The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Polymers Drug Delivery Market Research Report 2025
Synopsis
The global Polymers Drug Delivery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Polymers Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polymers Drug Delivery.
Report Scope
The Polymers Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polymers Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polymers Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Johnson & Johnson
Inovio Pharmaceuticals
Alkermes
Janssen Biotech
Heron
Eisai
Perrigo
Quark Pharmaceuticals Inc
Vectura Group Plc
SurModics
EnColl Corporation
Enzon Pharmaceuticals
Nektar Therapeutics
Allergan
Gilead Sciences
Tolmar
Segment by Type
Micelles
Microgels
Dendrimer
Hydrogels
Other
Segment by Application
Medical Research Center
Pharmaceutical Factory
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Polymers Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Polymers Drug Delivery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Polymers Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polymers Drug Delivery.
Report Scope
The Polymers Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polymers Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polymers Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Johnson & Johnson
Inovio Pharmaceuticals
Alkermes
Janssen Biotech
Heron
Eisai
Perrigo
Quark Pharmaceuticals Inc
Vectura Group Plc
SurModics
EnColl Corporation
Enzon Pharmaceuticals
Nektar Therapeutics
Allergan
Gilead Sciences
Tolmar
Segment by Type
Micelles
Microgels
Dendrimer
Hydrogels
Other
Segment by Application
Medical Research Center
Pharmaceutical Factory
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Polymers Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Polymers Drug Delivery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Micelles
1.2.3 Microgels
1.2.4 Dendrimer
1.2.5 Hydrogels
1.2.6 Other
1.3 Market by Application
1.3.1 Global Polymers Drug Delivery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical Research Center
1.3.3 Pharmaceutical Factory
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Polymers Drug Delivery Market Perspective (2019-2030)
2.2 Polymers Drug Delivery Growth Trends by Region
2.2.1 Global Polymers Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Polymers Drug Delivery Historic Market Size by Region (2019-2024)
2.2.3 Polymers Drug Delivery Forecasted Market Size by Region (2025-2030)
2.3 Polymers Drug Delivery Market Dynamics
2.3.1 Polymers Drug Delivery Industry Trends
2.3.2 Polymers Drug Delivery Market Drivers
2.3.3 Polymers Drug Delivery Market Challenges
2.3.4 Polymers Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Polymers Drug Delivery Players by Revenue
3.1.1 Global Top Polymers Drug Delivery Players by Revenue (2019-2024)
3.1.2 Global Polymers Drug Delivery Revenue Market Share by Players (2019-2024)
3.2 Global Polymers Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Polymers Drug Delivery Revenue
3.4 Global Polymers Drug Delivery Market Concentration Ratio
3.4.1 Global Polymers Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Polymers Drug Delivery Revenue in 2023
3.5 Polymers Drug Delivery Key Players Head office and Area Served
3.6 Key Players Polymers Drug Delivery Product Solution and Service
3.7 Date of Enter into Polymers Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Polymers Drug Delivery Breakdown Data by Type
4.1 Global Polymers Drug Delivery Historic Market Size by Type (2019-2024)
4.2 Global Polymers Drug Delivery Forecasted Market Size by Type (2025-2030)
5 Polymers Drug Delivery Breakdown Data by Application
5.1 Global Polymers Drug Delivery Historic Market Size by Application (2019-2024)
5.2 Global Polymers Drug Delivery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Polymers Drug Delivery Market Size (2019-2030)
6.2 North America Polymers Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Polymers Drug Delivery Market Size by Country (2019-2024)
6.4 North America Polymers Drug Delivery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Polymers Drug Delivery Market Size (2019-2030)
7.2 Europe Polymers Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Polymers Drug Delivery Market Size by Country (2019-2024)
7.4 Europe Polymers Drug Delivery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Polymers Drug Delivery Market Size (2019-2030)
8.2 Asia-Pacific Polymers Drug Delivery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Polymers Drug Delivery Market Size by Region (2019-2024)
8.4 Asia-Pacific Polymers Drug Delivery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Polymers Drug Delivery Market Size (2019-2030)
9.2 Latin America Polymers Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Polymers Drug Delivery Market Size by Country (2019-2024)
9.4 Latin America Polymers Drug Delivery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Polymers Drug Delivery Market Size (2019-2030)
10.2 Middle East & Africa Polymers Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Polymers Drug Delivery Market Size by Country (2019-2024)
10.4 Middle East & Africa Polymers Drug Delivery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Polymers Drug Delivery Introduction
11.1.4 Sanofi Revenue in Polymers Drug Delivery Business (2019-2024)
11.1.5 Sanofi Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Polymers Drug Delivery Introduction
11.2.4 Johnson & Johnson Revenue in Polymers Drug Delivery Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 Inovio Pharmaceuticals
11.3.1 Inovio Pharmaceuticals Company Detail
11.3.2 Inovio Pharmaceuticals Business Overview
11.3.3 Inovio Pharmaceuticals Polymers Drug Delivery Introduction
11.3.4 Inovio Pharmaceuticals Revenue in Polymers Drug Delivery Business (2019-2024)
11.3.5 Inovio Pharmaceuticals Recent Development
11.4 Alkermes
11.4.1 Alkermes Company Detail
11.4.2 Alkermes Business Overview
11.4.3 Alkermes Polymers Drug Delivery Introduction
11.4.4 Alkermes Revenue in Polymers Drug Delivery Business (2019-2024)
11.4.5 Alkermes Recent Development
11.5 Janssen Biotech
11.5.1 Janssen Biotech Company Detail
11.5.2 Janssen Biotech Business Overview
11.5.3 Janssen Biotech Polymers Drug Delivery Introduction
11.5.4 Janssen Biotech Revenue in Polymers Drug Delivery Business (2019-2024)
11.5.5 Janssen Biotech Recent Development
11.6 Heron
11.6.1 Heron Company Detail
11.6.2 Heron Business Overview
11.6.3 Heron Polymers Drug Delivery Introduction
11.6.4 Heron Revenue in Polymers Drug Delivery Business (2019-2024)
11.6.5 Heron Recent Development
11.7 Eisai
11.7.1 Eisai Company Detail
11.7.2 Eisai Business Overview
11.7.3 Eisai Polymers Drug Delivery Introduction
11.7.4 Eisai Revenue in Polymers Drug Delivery Business (2019-2024)
11.7.5 Eisai Recent Development
11.8 Perrigo
11.8.1 Perrigo Company Detail
11.8.2 Perrigo Business Overview
11.8.3 Perrigo Polymers Drug Delivery Introduction
11.8.4 Perrigo Revenue in Polymers Drug Delivery Business (2019-2024)
11.8.5 Perrigo Recent Development
11.9 Quark Pharmaceuticals Inc
11.9.1 Quark Pharmaceuticals Inc Company Detail
11.9.2 Quark Pharmaceuticals Inc Business Overview
11.9.3 Quark Pharmaceuticals Inc Polymers Drug Delivery Introduction
11.9.4 Quark Pharmaceuticals Inc Revenue in Polymers Drug Delivery Business (2019-2024)
11.9.5 Quark Pharmaceuticals Inc Recent Development
11.10 Vectura Group Plc
11.10.1 Vectura Group Plc Company Detail
11.10.2 Vectura Group Plc Business Overview
11.10.3 Vectura Group Plc Polymers Drug Delivery Introduction
11.10.4 Vectura Group Plc Revenue in Polymers Drug Delivery Business (2019-2024)
11.10.5 Vectura Group Plc Recent Development
11.11 SurModics
11.11.1 SurModics Company Detail
11.11.2 SurModics Business Overview
11.11.3 SurModics Polymers Drug Delivery Introduction
11.11.4 SurModics Revenue in Polymers Drug Delivery Business (2019-2024)
11.11.5 SurModics Recent Development
11.12 EnColl Corporation
11.12.1 EnColl Corporation Company Detail
11.12.2 EnColl Corporation Business Overview
11.12.3 EnColl Corporation Polymers Drug Delivery Introduction
11.12.4 EnColl Corporation Revenue in Polymers Drug Delivery Business (2019-2024)
11.12.5 EnColl Corporation Recent Development
11.13 Enzon Pharmaceuticals
11.13.1 Enzon Pharmaceuticals Company Detail
11.13.2 Enzon Pharmaceuticals Business Overview
11.13.3 Enzon Pharmaceuticals Polymers Drug Delivery Introduction
11.13.4 Enzon Pharmaceuticals Revenue in Polymers Drug Delivery Business (2019-2024)
11.13.5 Enzon Pharmaceuticals Recent Development
11.14 Nektar Therapeutics
11.14.1 Nektar Therapeutics Company Detail
11.14.2 Nektar Therapeutics Business Overview
11.14.3 Nektar Therapeutics Polymers Drug Delivery Introduction
11.14.4 Nektar Therapeutics Revenue in Polymers Drug Delivery Business (2019-2024)
11.14.5 Nektar Therapeutics Recent Development
11.15 Allergan
11.15.1 Allergan Company Detail
11.15.2 Allergan Business Overview
11.15.3 Allergan Polymers Drug Delivery Introduction
11.15.4 Allergan Revenue in Polymers Drug Delivery Business (2019-2024)
11.15.5 Allergan Recent Development
11.16 Gilead Sciences
11.16.1 Gilead Sciences Company Detail
11.16.2 Gilead Sciences Business Overview
11.16.3 Gilead Sciences Polymers Drug Delivery Introduction
11.16.4 Gilead Sciences Revenue in Polymers Drug Delivery Business (2019-2024)
11.16.5 Gilead Sciences Recent Development
11.17 Tolmar
11.17.1 Tolmar Company Detail
11.17.2 Tolmar Business Overview
11.17.3 Tolmar Polymers Drug Delivery Introduction
11.17.4 Tolmar Revenue in Polymers Drug Delivery Business (2019-2024)
11.17.5 Tolmar Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
